PREMIER ANTI-AGING CO., LTD. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 763 JPY | +0.53% |
|
-3.05% | -24.53% |
Valuation
| Fiscal Period: July | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 132,631 | 17,397 | 9,331 | 6,654 | - | - |
| Enterprise Value (EV) 1 | 127,480 | 15,837 | 6,825 | 6,379 | 7,421 | 8,126 |
| P/E ratio | 46.5 x | 12.2 x | -12.7 x | -2.66 x | -10.6 x | -88.7 x |
| Yield | - | - | - | - | - | - |
| Capitalization / Revenue | 4.04 x | 0.51 x | 0.35 x | 0.33 x | 0.33 x | 0.32 x |
| EV / Revenue | 3.88 x | 0.47 x | 0.26 x | 0.32 x | 0.37 x | 0.39 x |
| EV / EBITDA | - | 6.34 x | -16 x | -7.87 x | -19.5 x | 40.6 x |
| EV / FCF | - | -4.37 x | 4.49 x | -4.29 x | -12 x | 116 x |
| FCF Yield | - | -22.9% | 22.3% | -23.3% | -8.36% | 0.86% |
| Price to Book | 19.2 x | 2.08 x | 1.23 x | 1.3 x | 1.47 x | 1.49 x |
| Nbr of stocks (in thousands) | 8,720 | 8,720 | 8,720 | 8,720 | - | - |
| Reference price 2 | 15,210 | 1,995 | 1,070 | 763.0 | 763.0 | 763.0 |
| Announcement Date | 9/14/21 | 9/13/22 | 9/14/23 | - | - | - |
1JPY in Million2JPY
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: July | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Net sales 1 | 32,815 | 33,912 | 26,401 | 20,000 | 20,000 | 20,950 |
| EBITDA 1 | - | 2,500 | -427.6 | -810 | -380 | 200 |
| EBIT 1 | 4,680 | 2,414 | -611.7 | -1,000 | -575 | - |
| Operating Margin | 14.26% | 7.12% | -2.32% | -5% | -2.88% | - |
| Earnings before Tax (EBT) 1 | 4,653 | 2,572 | -659.5 | -2,000 | -600 | -300 |
| Net income 1 | 2,793 | 1,424 | -734 | -2,500 | -625 | -75 |
| Net margin | 8.51% | 4.2% | -2.78% | -12.5% | -3.12% | -0.36% |
| EPS 2 | 326.9 | 163.4 | -84.17 | -286.7 | -71.65 | -8.600 |
| Free Cash Flow 1 | - | -3,620 | 1,522 | -1,488 | -620 | 70 |
| FCF margin | - | -10.67% | 5.76% | -7.44% | -3.1% | 0.33% |
| FCF Conversion (EBITDA) | - | - | - | - | - | 35% |
| FCF Conversion (Net income) | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - |
| Announcement Date | 9/14/21 | 9/13/22 | 9/14/23 | - | - | - |
1JPY in Million2JPY
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: July | 2021 S1 | 2022 Q1 | 2022 Q2 | 2022 S1 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 S1 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 S1 | 2024 Q3 | 2024 Q4 | 2024 S2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 15,310 | 9,865 | 8,105 | 17,970 | 7,927 | 8,014 | 7,391 | 6,868 | 14,259 | 6,351 | 5,791 | 5,264 | 5,385 | 10,649 | 5,051 | 4,300 | 9,350 |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| EBIT 1 | 2,461 | 2,074 | 174 | 2,248 | -290.9 | 456.9 | -244 | 353 | 109 | -66.49 | -654.2 | -35 | -170 | -205 | -295 | -500 | - |
| Operating Margin | 16.07% | 21.02% | 2.15% | 12.51% | -3.67% | 5.7% | -3.3% | 5.14% | 0.76% | -1.05% | -11.3% | -0.66% | -3.16% | -1.93% | -5.84% | -11.63% | - |
| Earnings before Tax (EBT) | 2,454 | 2,132 | - | 2,321 | -180.3 | 431.3 | -224 | 319.2 | 95.24 | -51.79 | -674.7 | -26 | -1,082 | -1,108 | - | - | - |
| Net income 1 | 1,573 | 1,320 | 40 | 1,360 | -138 | 202 | -198 | 172 | -26.01 | -127.3 | -580.7 | -35 | -1,650 | -1,685 | -315 | -500 | - |
| Net margin | 10.27% | 13.38% | 0.49% | 7.57% | -1.74% | 2.52% | -2.68% | 2.5% | -0.18% | -2% | -10.03% | -0.66% | -30.64% | -15.82% | -6.24% | -11.63% | - |
| EPS | 187.8 | 151.4 | - | 156.0 | -15.83 | - | -22.71 | - | -2.980 | -14.60 | - | -4.090 | - | -193.2 | - | - | - |
| Dividend per Share | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Announcement Date | 3/15/21 | 12/14/21 | 3/14/22 | 3/14/22 | 6/13/22 | 9/13/22 | 12/14/22 | 3/14/23 | 3/14/23 | 6/14/23 | 9/14/23 | 12/14/23 | 3/14/24 | 3/14/24 | - | - | - |
1JPY in Million
Estimates
Balance Sheet Analysis
| Fiscal Period: July | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | - | 767 | 1,472 |
| Net Cash position 1 | 5,151 | 1,560 | 2,506 | 275 | - | - |
| Leverage (Debt/EBITDA) | - | - | - | - | -2.018 x | 7.36 x |
| Free Cash Flow 1 | - | -3,620 | 1,522 | -1,488 | -620 | 70 |
| ROE (net income / shareholders' equity) | 66.9% | 18.7% | -9.2% | -39.3% | -12.5% | -1.8% |
| ROA (Net income/ Total Assets) | - | 11.2% | -5.2% | -9.2% | -6.3% | -0.75% |
| Assets 1 | - | 12,686 | 14,115 | 27,174 | 9,921 | 10,000 |
| Book Value Per Share 2 | 792.0 | 957.0 | 873.0 | 587.0 | 518.0 | 511.0 |
| Cash Flow per Share | 332.0 | 173.0 | -63.00 | - | - | - |
| Capex 1 | 12 | 112 | 27.1 | 145 | 150 | 155 |
| Capex / Sales | 0.04% | 0.33% | 0.1% | 0.73% | 0.75% | 0.74% |
| Announcement Date | 9/14/21 | 9/13/22 | 9/14/23 | - | - | - |
1JPY in Million2JPY
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
763
JPY
Average target price
760
JPY
Spread / Average Target
-0.39%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -24.53% | 42M | |
| -3.10% | 251B | |
| +12.81% | 19.44B | |
| 0.00% | 17.73B | |
| +0.38% | 11.04B | |
| -7.37% | 10.11B | |
| +16.90% | 7.51B | |
| +10.15% | 5.97B | |
| -0.71% | 4.42B | |
| -18.27% | 3.7B |
- Stock Market
- Equities
- 4934 Stock
- Financials Premier Anti-Aging Co., Ltd.
